Abstract
Pharmacokinetic analysis of the behaviour of xenobiotics in living organisms is the basis for the understanding of dose (concentration-) response relationships. Risk estimates may lead to erroneous results if pharmacokinetic principles are neglected. The pharmacokinetic behaviour of a xenobiotic should be known before planning long-term experiments on toxicity and carcinogenicity. This is demonstrated using ethylene as an example.
On the basis of the pharmacokinetics in rats of ethylene and ethylene oxide, its carcinogenic metabolite, we estimated the theoretical risk for the carcinogenic potential of ethylene. Our results demonstrate that exposure of rats to ethylene concentrations higher than 1000 ppm correspond to a (theoretical) exposure to 5.6 ppm ethylene oxide: exposures to ethylene at 40 ppm are equivalent to ethylene oxide exposures of 1 ppm, which is the (new) TLV for ethylene oxide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ACGIH (1983) Threshold limit values for chemical substances and physical agents in the work environment with intended changes for 1983–4, American Conference of Governmental Industrial Hygienists, Cincinnati, Ohio, p 52
Andersen ME, Garges ML, Jones RA, Jenkins Jr LJ (1980) Determination of the kinetic constants for metabolism of inhaled toxicants in vivo using gas uptake measurements. Toxicol Appl Pharmacol 54: 100–116
Bolt HM, Filser JG, Buchter A (1981) Inhalation pharmacokinetics based on gas uptake studies. III. A pharmacokinetic assessment in man of “peak concentrations” of vinyl chloride. Arch Toxicol 48: 213–228
Bolt HM, Filser JG (1984) Olefinic hydrocarbons: A first risk estimate for ethene. Toxicol Pathol 12: 101–105
Bolt HM, Filser JG, Störmier F (1984) Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmaco-kinetics of ethylene and 1,3-butadiene in rats. Arch Toxicol 55: 213–218
Dunkelberg H (1982) Carcinogenicity of ethylene oxide and 1,2-propylene oxide upon intragastric administration to rats. Br J Cancer 46: 924–933
ECETOC (1982) Technical report No. 5. Toxicity of ethylene oxide and its relevance to man. European Chemical Industry Ecology & Toxicology Centre, Ave. Louise 250, Bruxelles
Ehrenberg L, Hiesche KD, Osterman-Golkar S, Wennberg I (1974) Evaluation of genetic risks of alkylating agents. Tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res 24: 83–103
Ehrenberg L, Osterman-Golkar S, Segerbäck D, Svensson K, Calleman CJ (1977) Evaluation of genetic risks of alkylating agets. III. Alkylation of haemoglobin after metabolic conversion of ethene to ethene oxide in vivo. Mutat Res 45: 175–184
Filser JG, Bolt HM (1979) Pharmacokinetics of halogenated ethylenes in rats. Arch Toxicol 42: 123–136
Filser JG, Bolt HM (1981) Inhalation pharmacokinetics based on gas uptake studies. I. Improvement of pharmacokinetic models. Arch Toxicol 47: 279–292
Filser JG, Bolt HM (1983) Exhalation of ethylene oxide by rats on exposure to ethylene. Mutat Res 120: 57–60
Filser JG, Bolt HM (1983a) Inhalation pharmacokinetics based on gas uptake studies. IV. The endogenous production of volatile compounds. Arch Toxicol 52: 123–133
Filser JG, Bolt HM (1984) Inhalation pharmacokinetics based on gas uptake studies. VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats. Arch Toxicol 55: 219–223
Garman RH, Snellings WM, Maronpot RR (1985) Brain tumors in F344 rats associated with chronic inhalation exposure to ethylene oxide. Neurotoxicol 6: 117–138
Hamm TE, Guest D, Dent JG (1984) Chronic toxicity and oncogenicity bioassay of inhaled, ethylene in Fischer-344 rats. Fund Appl Toxicol 4: 473–478
Harrison VC (1981) Ethylene, an ovulatory hormone? Lancet February 21: 438
Lynch DW, Lewis TR, Moorman WJ, Burg JR, Groth DH, Khan A, Ackerman LJ, Cockrell BY (1984) Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 rats. Toxicol Appl Pharmacol 76: 69–84
Pang KS, Gillette JR (1979) Sequential first-pass-elimination of a metabolite derived from a precursor. J Pharmacokinet Biopharm 7: 725
Sagai M, Ichinose T (1980) Age-related changes in lipid peroxidation as measured by ethane, ethylene, butane and pentane in respired gases of rats. Life Sci 27: 731–738
Schmiedel G, Filser JG, Bolt HM (1983) Rat liver microsomal transformation of ethene to oxirane in vitro. Toxicol Lett 19: 293–297
Segerbäck D (1983) Alkylation of DNA and hemoglobin in the mouse following exposure to ethene and ethene oxide. Chem Biol Interact 45: 139–151
Snellings WM, Weil CS, Maronpot RR (1981) Final report on ethylene oxide two-year inhalation study on rats. Project report 44-20, Bushy Run Research Center (formerly Carnegie-Mellon Institute of Research), January 28, 1981. Submitted by Union Carbide Corporation to the US Environmental Protection Agency under Section 8(e) of the Toxic Substances Control Act, on behalf of cosponsors of the study
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. med. Herbert Remmer on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Bolt, H.M., Filser, J.G. Kinetics and disposition in toxicology. Arch Toxicol 60, 73–76 (1987). https://doi.org/10.1007/BF00296951
Issue Date:
DOI: https://doi.org/10.1007/BF00296951